Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapy
Authors
Keywords
Neutrophil-to-lymphocyte ratio, Renal cell carcinoma, Sunitinib, Response
Journal
SpringerPlus
Volume 3, Issue 1, Pages 243
Publisher
Springer Nature
Online
2014-05-12
DOI
10.1186/2193-1801-3-243
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients
- (2012) Sandra Steffens et al. BMC CANCER
- Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?
- (2012) Bulent Cetin et al. Clinical Genitourinary Cancer
- Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients
- (2011) Basem Azab et al. ANNALS OF SURGICAL ONCOLOGY
- Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
- (2011) W Chua et al. BRITISH JOURNAL OF CANCER
- Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems
- (2011) G W A Lamb et al. BRITISH JOURNAL OF CANCER
- The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma
- (2011) Daniel Keizman et al. EUROPEAN JOURNAL OF CANCER
- Followup of Neutrophil-to-Lymphocyte Ratio and Recurrence of Clear Cell Renal Cell Carcinoma
- (2011) Yoshio Ohno et al. JOURNAL OF UROLOGY
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy
- (2010) S. C. H. Kao et al. CLINICAL CANCER RESEARCH
- Role of C-reactive protein as a biomarker for renal cell carcinoma
- (2010) Kazutaka Saito et al. Expert Review of Anticancer Therapy
- Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis
- (2010) Ying Wu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Pretreatment Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of Recurrence in Patients With Nonmetastatic Renal Cell Carcinoma
- (2010) Yoshio Ohno et al. JOURNAL OF UROLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer
- (2008) Donald C. McMillan PROCEEDINGS OF THE NUTRITION SOCIETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started